Sofia Haque

4.7k total citations · 1 hit paper
95 papers, 2.5k citations indexed

About

Sofia Haque is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Sofia Haque has authored 95 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 26 papers in Genetics. Recurrent topics in Sofia Haque's work include Glioma Diagnosis and Treatment (26 papers), Lung Cancer Treatments and Mutations (18 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Sofia Haque is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), Lung Cancer Treatments and Mutations (18 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Sofia Haque collaborates with scholars based in United States, India and Belarus. Sofia Haque's co-authors include David G. Pfister, Eric J. Sherman, Alan L. Ho, Matthew G. Fury, Ronglai Shen, Pat Zanzonico, Steven M. Larson, Nora Katabi, Ronald Ghossein and Shrujal S. Baxi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sofia Haque

88 papers receiving 2.5k citations

Hit Papers

Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyro... 2013 2026 2017 2021 2013 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
    2013 555 citations Alan L. Ho, Ravinder K. Grewal et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Haque United States 28 939 747 618 478 461 95 2.5k
Jae‐Kyung Won South Korea 31 879 0.9× 1.0k 1.4× 881 1.4× 510 1.1× 852 1.8× 134 3.4k
Florian Grabellus Germany 30 799 0.9× 784 1.0× 313 0.5× 622 1.3× 731 1.6× 103 2.7k
Andreas Schirbel Germany 35 1.4k 1.5× 432 0.6× 389 0.6× 608 1.3× 625 1.4× 106 3.1k
Hans-Jürgen Holzhausen Germany 26 612 0.7× 562 0.8× 464 0.8× 451 0.9× 532 1.2× 71 2.0k
J. Bryan Iorgulescu United States 28 458 0.5× 522 0.7× 207 0.3× 860 1.8× 407 0.9× 71 2.4k
P N Plowman United Kingdom 28 726 0.8× 482 0.6× 210 0.3× 955 2.0× 773 1.7× 94 2.8k
Marina Paola Gardiman Italy 29 336 0.4× 992 1.3× 392 0.6× 473 1.0× 834 1.8× 92 2.9k
Genichiro Ishii Japan 30 997 1.1× 588 0.8× 263 0.4× 374 0.8× 1.3k 2.9× 95 2.6k
José Cameselle‐Teijeiro Spain 39 1.6k 1.7× 1.6k 2.1× 1.7k 2.8× 638 1.3× 447 1.0× 143 4.3k
Folker E. Franke Germany 29 479 0.5× 1.1k 1.4× 197 0.3× 549 1.1× 334 0.7× 72 2.6k

Countries citing papers authored by Sofia Haque

Since Specialization
Citations

This map shows the geographic impact of Sofia Haque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Haque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Haque more than expected).

Fields of papers citing papers by Sofia Haque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Haque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Haque. The network helps show where Sofia Haque may publish in the future.

Co-authorship network of co-authors of Sofia Haque

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Haque. A scholar is included among the top collaborators of Sofia Haque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Haque. Sofia Haque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Souweidane, Mark M., Evan D. Bander, Pat Zanzonico, et al.. (2025). Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma. Neuro-Oncology. 27(8). 2117–2126. 4 indexed citations
2.
Gutman, David A., Andrei I. Holodny, Shakeel Modak, et al.. (2024). Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis Detection. Journal of Imaging Informatics in Medicine. 37(6). 2920–2930. 1 indexed citations
3.
Bander, Evan D., Andrew Garton, L. Pasquini, et al.. (2023). 213 A Positive Impact on Patterns of Relapse in Diffuse Intrinsic Pontine Glioma after Convection-Enhanced Delivery of Omburtamab. Neurosurgery. 69(Supplement_1). 38–38.
4.
5.
Sait, Sameer Farouk, Stephen W. Gilheeney, Tejus Bale, et al.. (2021). Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas. JCO Precision Oncology. 5(5). 876–883. 20 indexed citations
6.
Abramson, David H., Sofia Haque, & Jasmine H. Francis. (2020). Unilateral Retinoblastoma Metastatic to the Skull and Both Orbits. Ophthalmology Retina. 4(10). 1021–1021.
7.
Francis, Jasmine H., Sofia Haque, Ira J. Dunkel, et al.. (2019). Magnetic Resonance Imaging Screening for Trilateral Retinoblastoma. Ophthalmology Retina. 4(3). 327–335. 10 indexed citations
8.
Wang, Jiawan, Zhan Yao, Philip Jonsson, et al.. (2018). A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAF V600E-Mutant Brain Tumor. Cancer Discovery. 8(9). 1130–1141. 49 indexed citations
9.
Becher, Oren J., Shakeel Modak, Brian H. Kushner, et al.. (2017). A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors. PLoS ONE. 12(6). e0178593–e0178593. 36 indexed citations
10.
Jhaveri, Komal, Rui Wang, Eleonora Teplinsky, et al.. (2017). A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer. Breast Cancer Research. 19(1). 89–89. 46 indexed citations
11.
Das, Shukla, Deepika Pandhi, Gargi Rai, et al.. (2017). Challenges in culture-negative cases of Madurella mycetomatis: A case report re-accentuating PCR as an essential diagnostic tool. Journal de Mycologie Médicale. 27(4). 577–581. 5 indexed citations
12.
Becher, Oren J., Stephen W. Gilheeney, Yasmin Khakoo, et al.. (2016). A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors. Pediatric Blood & Cancer. 64(7). e26409–e26409. 50 indexed citations
13.
Ho, Alan L., Eric J. Sherman, Han Xiao, et al.. (2014). A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer. Investigational New Drugs. 32(3). 549–554. 3 indexed citations
14.
Fury, Matthew G., Eric J. Sherman, Alan L. Ho, et al.. (2013). A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. Cancer. 119(10). 1823–1831. 35 indexed citations
15.
Fury, Matthew G., Nancy Y. Lee, Eric J. Sherman, et al.. (2013). A Phase 1 Study of Everolimus + Weekly Cisplatin + Intensity Modulated Radiation Therapy in Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(3). 479–486. 45 indexed citations
16.
Beylergil, Volkan, Sofia Haque, A. Carver, Mark H. Bilsky, & Jorge A. Carrasquillo. (2013). Schwannomatosis/neurofibromatosis type 2 associated multiple schwannomas visualized on FDG-PET/CT. Revista Española de Medicina Nuclear e Imagen Molecular. 32(4). 275–276. 8 indexed citations
17.
Ho, Alan L., Ravinder K. Grewal, Rébecca Leboeuf, et al.. (2013). Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer. New England Journal of Medicine. 368(7). 623–632. 555 indexed citations breakdown →
18.
Fury, Matthew G., Nancy Y. Lee, Eric J. Sherman, et al.. (2012). A phase 2 study of bevacizumab with cisplatin plus intensity‐modulated radiation therapy for stage III/IVB head and neck squamous cell cancer. Cancer. 118(20). 5008–5014. 61 indexed citations
19.
Fischer, Cheryl, Sofia Haque, Jason T. Huse, et al.. (2012). Extraneural ependymoma: Distant bone, lung, liver, and lymph node metastases following bevacizumab. Pediatric Blood & Cancer. 60(1). 143–145. 11 indexed citations
20.
Fury, Matthew G., Eric J. Sherman, Nian Wu, et al.. (2010). Phase I study of everolimus (E) plus low-dose weekly cisplatin (C) for patients with advanced solid tumors.. Journal of Clinical Oncology. 28(15_suppl). e13013–e13013. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jae‐Kyung Won Breakdown of academic impact, for papers by Florian Grabellus Breakdown of academic impact, for papers by Andreas Schirbel Breakdown of academic impact, for papers by Hans-Jürgen Holzhausen Breakdown of academic impact, for papers by J. Bryan Iorgulescu Breakdown of academic impact, for papers by P N Plowman Breakdown of academic impact, for papers by Marina Paola Gardiman Breakdown of academic impact, for papers by Genichiro Ishii Breakdown of academic impact, for papers by José Cameselle‐Teijeiro Breakdown of academic impact, for papers by Folker E. Franke
Rankless by CCL
2026